Fatal burkholderia gladioli infection misidentified as empedobacter brevis in a lung transplant recipient with cystic fibrosis

Transplant Infectious Disease

Volumn 14, Issue 4, 2012, Pages

  Brizendine, K D ^a   Baddley, J W ^a,b   Pappas, P G ^a   Leon, K J ^c   Rodriguez, J M ^a  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Burkholderia; Burkholderia gladioli; Cystic fibrosis; Empedobacter brevis; Lung transplantation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ITRACONAZOLE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; TACROLIMUS; VALGANCICLOVIR; VORICONAZOLE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; BURKHOLDERIA GLADIOLI; BURKHOLDERIA GLADIOLI INFECTION; BURKHOLDERIA INFECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ERROR; EMPEDOBACTER BREVIS; EMPYEMA; FLAVOBACTERIUM; HUMAN; HUMAN TISSUE; LUNG ABSCESS; LUNG TRANSPLANTATION; MALE; MYCOSIS; NOCARDIOSIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; TRACHEOBRONCHITIS;

ADULT; BURKHOLDERIA GLADIOLI; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; DIAGNOSTIC ERRORS; FATAL OUTCOME; FLAVOBACTERIACEAE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; LUNG TRANSPLANTATION; MALE;

EID: 84865168344     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00726.x     Document Type: Article

References (20)

1. Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. Rockville, MD: Health Resources And Services Administration, Healthcare Systems Bureau, Division Of Transplantation, 2008.
2. Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997; 155: 1699-1704.
3. Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001; 163: 43-48.
4. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993; 103: 466-471.
5. Egan JJ, McNeil K, Bookless B, et al. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet 1994; 344: 552-553.
6. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004; 125: 1224-1238.
7. Coenye T, Vandamme P, Govan JRW, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 2001; 39: 3427-3436.
8. Christenson JC, Welch DF, Mukwaya G, Muszynski MJ, Weaver RE, Brenner DJ. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol 1989; 27: 270-273.
9. Egan TM, Detterbeck FC, Mill MR, et al. Long-term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 2002; 22: 602-609.
10. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001; 164: 2102-2106.
11. McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1, 051 recent sputum isolates. Chest 2000; 117: 1661-1665.
12. O'Hara CM, Miller JM. Ability of the MicroScan rapid gram-negative ID type 3 panel to identify nonenteric glucose-fermenting and nonfermenting gram-negative bacilli. J Clin Microbiol 2002; 40: 3750-3752.
13. Segonds C, Heulin T, Marty N, Chabanon G. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 1999; 37: 2201-2208.
14. Church AC, Sivasothy P, Parmer J, Foweraker J. Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection. J Heart Lung Transplant 2009; 28: 511-514.
15. Jones AM, Stanbridge TN, Isalska BJ, Dodd ME, Webb AK. Burkholderia gladioli: recurrent abscesses in a patient with cystic fibrosis. J Infect 2001; 42: 69-71.
16. Khan SU, Gordon SM, Stillwell PC, et al. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplant. Ped Infect Dis J 1996; 15: 637-639.
17. Kanj SS, Tapson V, Davis RD, Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997; 112: 924-930.
18. Kennedy MP, Coakley RD, Donaldson SH, et al. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros 2007; 6: 267-273.
19. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 363-371.
20. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006; 6: 1212-1227.